ES2361350B1 - HYPERPIGMENTARY STAIN ELIMINATING CREAM FOR FACE SKIN AND ITS USE. - Google Patents
HYPERPIGMENTARY STAIN ELIMINATING CREAM FOR FACE SKIN AND ITS USE. Download PDFInfo
- Publication number
- ES2361350B1 ES2361350B1 ES200902286A ES200902286A ES2361350B1 ES 2361350 B1 ES2361350 B1 ES 2361350B1 ES 200902286 A ES200902286 A ES 200902286A ES 200902286 A ES200902286 A ES 200902286A ES 2361350 B1 ES2361350 B1 ES 2361350B1
- Authority
- ES
- Spain
- Prior art keywords
- skin
- application
- hydroquinone
- hyperpigmentary
- art
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000006071 cream Substances 0.000 title claims abstract description 15
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims abstract description 20
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 14
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 claims abstract description 9
- 229960001727 tretinoin Drugs 0.000 claims abstract description 8
- 239000011718 vitamin C Substances 0.000 claims abstract description 8
- 239000011709 vitamin E Substances 0.000 claims abstract description 8
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 7
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims abstract description 7
- 229930002330 retinoic acid Natural products 0.000 claims abstract description 7
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 7
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 7
- 229940046009 vitamin E Drugs 0.000 claims abstract description 7
- 239000004251 Ammonium lactate Substances 0.000 claims abstract description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 6
- 229940059265 ammonium lactate Drugs 0.000 claims abstract description 6
- 229960004703 clobetasol propionate Drugs 0.000 claims abstract description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims abstract description 6
- 235000019286 ammonium lactate Nutrition 0.000 claims abstract description 5
- RZOBLYBZQXQGFY-HSHFZTNMSA-N azanium;(2r)-2-hydroxypropanoate Chemical compound [NH4+].C[C@@H](O)C([O-])=O RZOBLYBZQXQGFY-HSHFZTNMSA-N 0.000 claims abstract description 5
- 239000002537 cosmetic Substances 0.000 claims abstract description 3
- 229940100611 topical cream Drugs 0.000 claims abstract description 3
- 229960004337 hydroquinone Drugs 0.000 claims description 10
- 230000001815 facial effect Effects 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 7
- 230000036074 healthy skin Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 230000001172 regenerating effect Effects 0.000 claims description 3
- 230000000699 topical effect Effects 0.000 claims description 3
- 230000006866 deterioration Effects 0.000 claims description 2
- 229960002842 clobetasol Drugs 0.000 claims 4
- 206010040865 Skin hyperpigmentation Diseases 0.000 claims 3
- 241000548911 Rosalia Species 0.000 claims 2
- 235000010323 ascorbic acid Nutrition 0.000 claims 2
- 239000011668 ascorbic acid Substances 0.000 claims 2
- 229960005070 ascorbic acid Drugs 0.000 claims 2
- 239000007844 bleaching agent Substances 0.000 claims 2
- 229930003799 tocopherol Natural products 0.000 claims 2
- 235000010384 tocopherol Nutrition 0.000 claims 2
- 229960001295 tocopherol Drugs 0.000 claims 2
- 239000011732 tocopherol Substances 0.000 claims 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 1
- -1 Lactatoamonic Chemical compound 0.000 claims 1
- 208000012641 Pigmentation disease Diseases 0.000 claims 1
- RZOBLYBZQXQGFY-UHFFFAOYSA-N ammonium lactate Chemical compound [NH4+].CC(O)C([O-])=O RZOBLYBZQXQGFY-UHFFFAOYSA-N 0.000 claims 1
- 239000007854 depigmenting agent Substances 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- 229940001447 lactate Drugs 0.000 claims 1
- 230000019612 pigmentation Effects 0.000 claims 1
- 102220240796 rs553605556 Human genes 0.000 claims 1
- 239000003009 skin protective agent Substances 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 230000002087 whitening effect Effects 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 3
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000009323 psychological health Effects 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Crema eliminadora de machas para la piel de la cara y su utilización del tipo que se constituye en una mezcla de diversos productos o componentes químicos en proporciones determinadas que dan como resultado una crema de uso tópico adecuada para el tratamiento cosmético y dermatológico destinado a eliminar las manchas hiperpigmentarias de la piel de la cara, que comprende un 16,65% de vitamina E, un 16,65 de vitamina C, un 39,85% de lactato amónico, un 0,15% de clobetasol propionato, un 0,15% de acido retinoico y un 26,55% de hidroquinona.Cleansing cream for stains on the skin of the face and its use of the type that constitutes a mixture of various products or chemical components in certain proportions that result in a topical cream suitable for cosmetic and dermatological treatment to eliminate hyperpigmentary spots on the skin of the face, comprising 16.65% of vitamin E, 16.65 of vitamin C, 39.85% of ammonium lactate, 0.15% of clobetasol propionate, 0.15 % retinoic acid and 26.55% hydroquinone.
Description
Crema eliminadora de manchas hiperpigmentarias para la piel de la cara y su utilización. Hyperpigmentary stain removal cream for facial skin and its use.
Objeto de la invención Object of the invention
La presente memoria descriptiva se refiere a la solicitud de Patente de Invención, tal como expresa el enunciado de una crema para la eliminación de manchas hiperpigmentarias de la piel de la cara y su utilización. The present specification refers to the application for an Invention Patent, as stated in the statement of a cream for the removal of hyperpigmentary spots on the skin of the face and its use.
Más concretamente, el objeto de la invención es una mezcla de diversos productos o componentes químicos en proporciones determinadas que dan como resultado una crema de uso tópico adecuado para el tratamiento cosmético y dermatológico destinado a eliminar las manchas hiperpigmentarias de la piel de la cara y del procedimiento para su preparación y su utilización. More specifically, the object of the invention is a mixture of various products or chemical components in determined proportions that result in a topical cream suitable for cosmetic and dermatological treatment intended to remove hyperpigmentary spots on the skin of the face and skin. procedure for its preparation and its use.
Antecedentes de la invención Background of the invention
Es sabido la importancia del cuidado de la piel tanto para mejorar la apariencia estética como para gozar de una buena salud física como psicológica, sobre todo si se trata de manchas dérmicas en la cara. It is known the importance of skin care both to improve the aesthetic appearance and to enjoy good physical and psychological health, especially if it is dermal spots on the face.
Para ello, el eliminarlas constituye un objetivo primordial sanitario y social para muchas personas, mediante un preparado que respete la integridad de la epidermis y la dermis sana, aportando elementos abrasivos pero también regenerativos en proporciones idóneas para obtener el efecto deseado final, que no es otro, que la eliminación de manchas respetando la piel sana. To do this, eliminating them constitutes a primary health and social objective for many people, through a preparation that respects the integrity of the epidermis and the healthy dermis, providing abrasive but also regenerative elements in suitable proportions to obtain the desired final effect, which is not another, that the removal of spots respecting healthy skin.
Existen diferentes tipos de manchas faciales de múltiples orígenes. Una vez descartadas las lesiones precancerosas y el melanoma, uno de los tipos de manchas mas frecuentes son el tipo marrón y “café con leche”, hiperpigmentadas (hiperconcentración de melanina), cuyas causas más frecuentes son la exposición al sol y el envejecimiento dérmico. There are different types of facial blemishes of multiple origins. Once the precancerous lesions and melanoma have been ruled out, one of the most frequent types of spots are the brown and “coffee with milk” type, hyperpigmented (melanin hyperconcentration), whose most frequent causes are sun exposure and dermal aging.
En orden a eliminar estas últimas, el peticionario preconiza la presente invención señalando desconocer la existencia de ninguna otra que presente unas características semejantes. In order to eliminate the latter, the petitioner advocates the present invention by not knowing the existence of any other that has similar characteristics.
Explicación de la invención Explanation of the invention.
En concreto, la invención consiste en una crema eliminadora de manchas faciales constituida por una mezcla cuya composición incorpora un 16,65% de Vitamina E, un 16,65% de Vitamina C, un 39,85% de Lactato amónico, un0,15% de Clobetasol propionato, un 0,15% de Ácido retinoico y un 26,55% de Hidroquinona siendo el procedimiento de preparación de la misma el siguiente: Specifically, the invention consists of a facial stain removal cream consisting of a mixture whose composition incorporates 16.65% Vitamin E, 16.65% Vitamin C, 39.85% Ammonium Lactate, 0.15 % of Clobetasol propionate, 0.15% of Retinoic acid and 26.55% of Hydroquinone, the preparation procedure being as follows:
1 Incorporar VitaminaEyVitamina C y agitar hasta su total mezcla. 1 Incorporate Vitamin E and Vitamin C and stir until completely mixed.
2 Añadir Lactato amónico, Clobetasol propionato, Ácido retinoico e Hidroquinona y remover hasta su total mezcla. 2 Add Ammonium lactate, Clobetasol propionate, Retinoic acid and Hydroquinone and stir until completely mixed.
3 Envasar en el material de acondicionamiento. 3 Pack in the conditioning material.
4 Realizar los controles microbiológicos entre las 24 y 48 horas de su envasado final. 4 Perform microbiological controls between 24 and 48 hours after final packaging.
En base a la suma y potenciación de tales componentes, la crema de la invención aplicada de forma tópica sobre la piel facial y usada con regularidad produce una acción eliminadora de las manchas hiperpigmentarias de la piel, actuando con un doble efecto en equilibrio: la eficacia de sus componentes abrasivos y la de sus componentes regenerativos, balance este fundamental de su acción que permite alcanzar su objetivo final sin dañar la piel sana. Based on the sum and enhancement of such components, the cream of the invention applied topically to the facial skin and used regularly produces an action that removes hyperpigmentary skin blemishes, acting with a double equilibrium effect: the effectiveness of its abrasive components and that of its regenerative components, balance this fundamental of its action that allows it to reach its ultimate goal without damaging healthy skin.
Con la utilización de la crema eliminadora de manchas de la invención, se han observado también excelentes resultados en la tersura y limpieza de la piel facial, dejando como resultado un cutis, de aspecto sano y sin manchas. With the use of the stain remover cream of the invention, excellent results have also been observed in the smoothness and cleansing of the facial skin, resulting in a complexion, healthy appearance and without spots.
Al tratarse de un producto que carece absolutamente de excipientes así como de colorantes o de conservantes, se constituye como una mezcla que proporciona buenos resultados en cualquier tipo de piel, siendo inexistentes cualquier tipo de contraindicaciones de uso, incluso durante el embarazo, y careciendo de posibles efectos adversos o secundarios, a excepción hecha de la existencia de algún tipo de alergia tópica a alguno de sus componentes. Being a product that absolutely lacks excipients as well as dyes or preservatives, it is constituted as a mixture that provides good results in any type of skin, any type of contraindications for use, even during pregnancy, and lacking possible adverse or side effects, except for the existence of some type of topical allergy to any of its components.
La crema eliminadora de manchas faciales de la invención, representa, por consiguiente, una composición innovadora de características desconocidas hasta ahora, razones que unidas a su utilidad práctica le dotan de fundamento suficiente para obtener el privilegio de exclusividad que se solicita. The facial stain remover cream of the invention, therefore, represents an innovative composition with characteristics unknown until now, reasons that together with its practical utility provide it with a sufficient basis for obtaining the privilege of exclusivity that is requested.
Realización preferente de la invención Preferred Embodiment of the Invention
A continuación se describirá de forma más detallada un ejemplo de realización de la mezcla de los componentes de la crema eliminadora de manchas según la invención, en el cual las cantidades se facilitan en porcentaje ponderal: An embodiment of the mixture of the components of the stain remover cream according to the invention will be described in more detail below, in which the amounts are given in weight percentage:
- -Vitamina E -Vitamin E
- 16,65 16.65
- -Vitamina C -Vitamin C
- 16,65 16.65
- -Lactato amónico -Ammonium lactate
- 39,85 39.85
- -Clobetasol propionato -Clobetasol propionate
- 0,15 0.15
- -Ácido retinoico -Retinoic acid
- 0,15 0.15
- -Hidroquinona -Hydroquinone
- 26,55 26.55
La mezcla se presenta en forma de una crema destinada a la eliminación de manchas hiperpigmentarias de la piel de la cara sin daño ni deterioro de la piel sana. The mixture comes in the form of a cream aimed at the removal of hyperpigmentary spots on the skin of the face without damage or deterioration of healthy skin.
Descrita suficientemente la naturaleza de la presente invención, así como la manera de ponerla en práctica, se hace constar que, dentro de su esencialidad, podrá ser llevada a la práctica en otras formas de realización que difieran en detalle de la indicada a título de ejemplo y a las cuales alcanzará igualmente la protección que se recaba siempre que no se altere, cambie o modifique su principio fundamental. Sufficiently described the nature of the present invention, as well as the manner of putting it into practice, it is stated that, within its essentiality, it may be carried out in other embodiments that differed in detail from that indicated by way of example. and which will also achieve the protection that is sought as long as it does not alter, change or modify its fundamental principle.
Claims (4)
- 1. one.
- Crema eliminadora de manchas hiperpigmentarias de la piel de la cara, del tipo que se constituye de una mezcla de diversos productos o componentes químicos en proporciones determinadas que dan como resultado una crema de uso tópico adecuada para el tratamiento cosmético y dermatológico destinado a eliminar las manchas hiperpigmentarias de la piel de la cara, caracterizada por el hecho de comprender una cantidad de Vitamina E, Vitamina C, Lactatoamónico, Clobetasol propionato, Ácido retinoico e Hidroquinona. Hyperpigmentary stain removal cream on the skin of the face, of the type that consists of a mixture of various products or chemical components in certain proportions that result in a topical cream suitable for cosmetic and dermatological treatment aimed at removing stains hyperpigmentary skin of the face, characterized by the fact that it comprises an amount of Vitamin E, Vitamin C, Lactatoamonic, Clobetasol Propionate, Retinoic Acid and Hydroquinone.
- 2. 2.
- Crema eliminadora de manchas hiperpigmentarias de la piel de la cara, según la reivindicación 1, caracterizada por el hecho de que la cantidad que contiene de Vitamina E es de un 16, 65%, de Vitamina C es de un 16,65%, deLactato amónico es de un 39,85%, de Clobetasol propionato es de un 0,15%, de Ácido retinoico es de un 0,15% y de Hidroquinona es de un 26,55%. Hyperpigmentary stain removal cream on the face skin according to claim 1, characterized in that the amount it contains of Vitamin E is 16, 65%, of Vitamin C is 16.65%, of Lactate Ammonium is 39.85%, Clobetasol Propionate is 0.15%, Retinoic Acid is 0.15% and Hydroquinone is 26.55%.
- 3. 3.
- Utilización de la crema eliminadora de manchas hiperpigmentarias de la piel de la cara, según las reivindicaciones1y2, para la eliminación de las manchas de tipo “hiperpigmentarias” de la piel facial, a través de un efecto abrasivo intenso compensado por un efecto regenerativo de igual o superior intensidad sin daño ni deterioro de la piel sana, resultando adicionalmente una tersura y limpieza de la piel facial dando al cutis un aspecto sano y sin manchas si se aplica regularmente. Use of the hyperpigmentary stain remover cream of the facial skin, according to claims 1 and 2, for the removal of the "hyperpigmentary" spots of the facial skin, through an intense abrasive effect compensated by a regenerative effect of equal or Higher intensity without damage or deterioration of healthy skin, additionally resulting in a smoothness and cleansing of the facial skin giving the complexion a healthy and spotless appearance if applied regularly.
- Categoría Category
- Documentos citados Reivindicaciones afectadas Documents cited Claims Affected
- Y Y
- MX 2007006059 A (FLORES ROSALIA RODRIGUEZ) 25.02.2009, todo el documento; ver reivindicaciones. 1-3 MX 2007006059 A (FLORES ROSALIA RODRIGUEZ) 25.02.2009, the whole document; see claims. 1-3
- Y Y
- WO 02094251 A1 (MEDICIS PHARMACEUTICAL CORP) 28.11.2002, página 2, párrafo 9; ejemplo 2; reivindicaciones 1,24. 1-3 WO 02094251 A1 (MEDICIS PHARMACEUTICAL CORP) 28.11.2002, page 2, paragraph 9; example 2; claims 1.24. 1-3
- Y Y
- US 5262153 A (MISHIMA YUTAKA et al.) 16.11.1993, ejemplo 2; reivindicaciones 1-3. 1-3 US 5262153 A (MISHIMA YUTAKA et al.) 16.11.1993, example 2; claims 1-3. 1-3
- A TO
- US 2006099173 A1 (PUGLIA NANCY et al.) 11.05.2006, todo el documento. 1-3 US 2006099173 A1 (PUGLIA NANCY et al.) 11.05.2006, the whole document. 1-3
- A TO
- US 2002071816 A1 (PERRICONE NICHOLAS V) 13.06.2002, todo el documento. 1-3 US 2002071816 A1 (PERRICONE NICHOLAS V) 06.16.2002, the whole document. 1-3
- A TO
- US 5932612 A (GORDON BENJAMIN D et al.) 03.08.1999, todo el documento. 1-3 US 5932612 A (GORDON BENJAMIN D et al.) 03.08.1999, the whole document. 1-3
- Categoría de los documentos citados X: de particular relevancia Y: de particular relevancia combinado con otro/s de la misma categoría A: refleja el estado de la técnica O: referido a divulgación no escrita P: publicado entre la fecha de prioridad y la de presentación de la solicitud E: documento anterior, pero publicado después de la fecha de presentación de la solicitud Category of the documents cited X: of particular relevance Y: of particular relevance combined with other / s of the same category A: reflects the state of the art O: refers to unwritten disclosure P: published between the priority date and the date of priority submission of the application E: previous document, but published after the date of submission of the application
- El presente informe ha sido realizado • para todas las reivindicaciones • para las reivindicaciones nº: This report has been prepared • for all claims • for claims no:
- Fecha de realización del informe 23.02.2011 Date of realization of the report 23.02.2011
- Examinador A. Maquedano Herrero Página 1/4 Examiner A. Maquedano Herrero Page 1/4
- Novedad (Art. 6.1 LP 11/1986) Novelty (Art. 6.1 LP 11/1986)
- Reivindicaciones Reivindicaciones 1-3 SI NO Claims Claims 1-3 IF NOT
- Actividad inventiva (Art. 8.1 LP11/1986) Inventive activity (Art. 8.1 LP11 / 1986)
- Reivindicaciones Reivindicaciones 1-3 SI NO Claims Claims 1-3 IF NOT
- Documento Document
- Número Publicación o Identificación Fecha Publicación Publication or Identification Number publication date
- D01 D01
- MX 2007006059 A (FLORES ROSALIA RODRIGUEZ) 25.02.2009 MX 2007006059 A (FLOWERS ROSALIA RODRIGUEZ) 02.25.2009
- D02 D02
- WO 02094251 A1 (MEDICIS PHARMACEUTICAL CORP) 28.11.2002 WO 02094251 A1 (PHARMACEUTICAL CORP MEDICIS) 11.28.2002
- D03 D03
- US 5262153 A (MISHIMA YUTAKA et al.) 16.11.1993 US 5262153 A (MISHIMA YUTAKA et al.) 16.11.1993
- D04 D04
- US 2006099173 A1 (PUGLIA NANCY et al.) 11.05.2006 US 2006099173 A1 (PUGLIA NANCY et al.) 11.05.2006
- D05 D05
- US 2002071816 A1 ( PERRICONE NICHOLAS V) 13.06.2002 US 2002071816 A1 (PERRICONE NICHOLAS V) 06-13-2002
- D06 D06
- US 5932612 A (GORDON BENJAMIN D et al.) 03.08.1999 US 5932612 A (GORDON BENJAMIN D et al.) 03.08.1999
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200902286A ES2361350B1 (en) | 2009-12-04 | 2009-12-04 | HYPERPIGMENTARY STAIN ELIMINATING CREAM FOR FACE SKIN AND ITS USE. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200902286A ES2361350B1 (en) | 2009-12-04 | 2009-12-04 | HYPERPIGMENTARY STAIN ELIMINATING CREAM FOR FACE SKIN AND ITS USE. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2361350A1 ES2361350A1 (en) | 2011-06-16 |
| ES2361350B1 true ES2361350B1 (en) | 2012-01-19 |
Family
ID=44072465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES200902286A Expired - Fee Related ES2361350B1 (en) | 2009-12-04 | 2009-12-04 | HYPERPIGMENTARY STAIN ELIMINATING CREAM FOR FACE SKIN AND ITS USE. |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2361350B1 (en) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2593714B2 (en) * | 1989-09-20 | 1997-03-26 | 株式会社 林原生物化学研究所 | Whitening agent |
| US5932612A (en) * | 1997-08-05 | 1999-08-03 | Medicis Pharmaceutical Corp. | Compositions and systems for the treatment of hyperpigmentation |
| US6417226B1 (en) * | 2000-12-12 | 2002-07-09 | Nicholas V. Perricone | Skin whiteners containing hydroxytetronic acid |
| US7189759B2 (en) * | 2001-05-23 | 2007-03-13 | Medicis Pharmaceutical Corporation | Compositions for the treatment of pigmentation disorders and methods for their manufacture |
| US20060099173A1 (en) * | 2003-10-24 | 2006-05-11 | Nancy Puglia | Topical skin care composition |
| MX2007006059A (en) * | 2007-05-21 | 2009-02-25 | Rosalia Rodriguez Flores | Composition for removal of skin pigmentation. |
-
2009
- 2009-12-04 ES ES200902286A patent/ES2361350B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2361350A1 (en) | 2011-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103156786B (en) | A non-additive anti-aging cosmetic | |
| BR112015020196A2 (en) | a topical whitening composition and methods of using it | |
| JPWO2004016236A1 (en) | Cosmetics | |
| MX2010009312A (en) | Preserved product; and preservative composition. | |
| JP2025108661A (en) | Composition for external use containing ascorbic acid and/or its salt | |
| ES2714075T3 (en) | Dermatological kit comprising compositions based on hibiscus flower and buriti oil | |
| ES2361350B1 (en) | HYPERPIGMENTARY STAIN ELIMINATING CREAM FOR FACE SKIN AND ITS USE. | |
| CN104352384A (en) | Serum with anti-aging benefits | |
| RU2557894C2 (en) | Cosmetic product for fast skin repair | |
| CN105769702A (en) | Mask containing bromelain and manufacturing method thereof | |
| ES2541379B1 (en) | Acorn natural cosmetics | |
| ES2716883T3 (en) | Association of active agents for oral administration to improve the quality of nails | |
| ES2380862B2 (en) | CREAM OF SHAVING FOR THE TREATMENT OF ACNE AND IRRITATIONS AND INFECTIONS CAUSED BY ACNE. | |
| ES2351006B1 (en) | COSMETIC COMPOSITION CHARACTERIZED FOR CONTAINING AT LEAST A FLORAL ESSENCE NEXT TO AT LEAST, AN ESSENTIAL OIL | |
| ES2778853T3 (en) | Liquid mixture containing 4- (3-ethoxy-4-hydroxyphenyl) butan-2-one and xanthine compound | |
| ES2364207B1 (en) | MASSAGE COMPOSITION AFTER SHAVING MIXING TWO INGREDIENTS TO EQUAL PARTS: COLONIA WATER FROM LAVENDER AND BODY MILK CONTAINING GLICERINE; PRODUCT KNOWN AS BALSAMO | |
| ES2264902B1 (en) | MOISTURIZING-NUTRITIVE OIL FOR THE SKIN. | |
| Gupta et al. | A review article on anti-aging herbal cream | |
| ES2952437B2 (en) | Composition of plant extracts to alleviate the effects of aging by preventing or delaying cellular senescence | |
| ES2393338B1 (en) | USE OF PHOTOLIASA FOR THE REDUCTION OR IMPROVEMENT OF THE SUBCLINICAL CANCERIZATION FIELD ASSOCIATED WITH ACTINAL KERATOSIS. | |
| JP7789671B2 (en) | Composition for external use on skin containing ascorbic acid and/or its salt | |
| ES2427423A1 (en) | Cosmetic composition for hair and scalp treatment | |
| BR112017022026A2 (en) | prolonged hydration cosmetic formulation compositions comprising high myristic acid concentration ucuuba butter, as well as use of said formulation for preparation of a high hydrating power cosmetic product and kit | |
| Ellenberger | Smart skincare after wearing a mask | |
| Caputo | The spectrum of treatments for photodamage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 2361350 Country of ref document: ES Kind code of ref document: B1 Effective date: 20120119 |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20210928 |